2013 - Program Agenda
Wednesday - Thursday - Friday - Saturday
Wednesday, October 2, 2013
| 12:00pm - 1:30pm | Lunch Symposium (non-CME) Consider the Role of the Kidney in Type 2 Diabetes Mellitus Sponsored by Janssen Pharmaceuticals, Inc. |
David S. H. Bell, MB |
| 1:30pm - 2:45pm | Afternoon Symposium (non-CME) A Novel Treatment Option for Chronic Weight Management Sponsored by Eisai, Inc. |
Robert J. Chilton, DO |
| 2:45pm - 4:00pm | Afternoon Symposium A (non-CME) The Role of the Kidney in T2DM Pathophysiology Sponsored by Bristol-Myers Squibb and AstraZeneca LP |
Paresh Dandona, MD |
| 2:45pm - 4:00pm | Afternoon Symposium B (non-CME) AZOR® and TRIBENZOR®: Fixed-Dose Combination Therapy Sponsored by Daiichi Sankyo, Inc. |
Robert Busch, MD |
| 4:00pm - 5:15pm | Afternoon Symposium Cardiometabolic Risk in Racial/Ethnic Minorities: Unique Aspects and Practical Solutions Sponsored by the American College of Cardiology in collaboration with the National Minority Quality Forum and the Association of Black Cardiologists. |
Keith C. Ferdinand, MD JoAnne Foody, MD Gary Puckrein, PhD Laurence Sperling, MD Tracy Wang, MD |
| 5:15pm - 6:45pm | Early Evening Symposium (non-CME) Advancements in Cardiometabolic Risk Assessment: Expert Analysis of Recent Evidence and Outcomes Sponsored by Atherotech Diagnostics Lab |
Eliot Brinton, MD Peter McCullough, MD, MPH Peter Toth, MD, PhD |
| 7:00pm - 8:30pm | Dinner Symposium A (non-CME) Chronic Management of Obesity: The Role of a Unique, Once-Daily Treatment Sponsored by VIVUS, Inc. |
W. Timothy Garvey, MD |
| 7:00pm - 8:30pm | Dinner Symposium B (non-CME) KYNAMRO (mipomersen sodium) injection: An Overview for Clinicians Sponsored by Genzyme, A SANOFI COMPANY |
Sotirios Tsimikas, MD |
Thursday, October 3, 2013
| 6:15am - 7:45am | Breakfast Symposium A State-of-the-Art Antiplatelet Therapy for Patients with ACS: Expert Analysis & Evidence-Based Guidelines for Optimizing Patient Outcomes Supported by an educational grant from AstraZeneca |
Deepak L. Bhatt, MD, MPH Robert Harrington, MD E. Magnus Ohman, MD Marc Sabatine, MD, MPH |
| 6:15am - 7:45am | Breakfast Symposium B New Strategies for Obesity Management & Cardiometabolic Risk Reduction: Expert Perspectives on Novel Therapies Targeting the CNS Supported by an educational grant from Eisai, Inc. |
Louis Aronne, MD Harold Bays, MD Lee M. Kaplan, MD, PhD Steven Smith, MD |
| 8:00am - 8:10am | Opening Remarks | Christie Ballantyne, MD |
| 8:10am - 8:50am | Keynote Session: Inflammation & Cardiometabolic Risk | Peter Libby, MD |
| 8:50am - 10:00am | Late-Breaking Clinical Trials & FDA Update | Moderator: Christie Ballantyne, MD Presenters & Discussants: Deepak L. Bhatt, MD, MPH Robert Eckel, MD Keith C. Ferdinand, MD Jay Skyler, MD, MACP |
| 10:00am - 11:00am | Morning Break/Exhibit Hall Sponsored by Takeda Pharmaceuticals U.S.A., Inc. |
|
| 11:00am - 12:00pm | Hot Topics in ACS: Debate | Moderator: Deepak L. Bhatt, MD, MPH Presenters & Discussants: Robert Harrington, MD Daniel Simon, MD |
| 12:15pm - 1:45pm | Lunch Symposium A Triglyceride & Mixed Dyslipidemia Management: Expert Analysis of Cutting-Edge Data & Evidence-Based Recommendations for Reducing Residual CV Risk Supported by an educational grant from Amarin Pharma, Inc. |
Christie Ballantyne, MD Harold Bays, MD Deepak L. Bhatt, MD, MPH Sergio Fazio, MD, PhD Terry Jacobson, MD |
| 12:15pm - 1:45pm | Lunch Symposium B Alternate Pathways for the Management of Type 2 Diabetes: Expert Analysis on Targeting Dopamine & the CNS for Glycemic Control & CV Risk Reduction Supported by an educational grant from Santarus, Inc. |
David S. H. Bell, MB Samuel Dagogo-Jack, MD J. Michael Gaziano, MD, MPH Jay Skyler, MD, MACP |
| 12:15pm - 1:45pm | Lunch Symposium C Personalized SIHD Management: Evidence-Based Decision Making for Patients at Increased Cardiometabolic Risk Supported by an independent educational grant from Gilead Sciences, Inc. |
JoAnne Foody, MD Robert Harrington, MD Mikhail Kosiborod, MD David Morrow, MD, MPH |
| 2:00pm - 2:45pm | Keynote Session: Translating Insights from Human Genetics into Novel Therapies for Dyslipidemia | Daniel Rader, MD |
| 2:45pm - 3:30pm | Biomarkers vs. Imaging for CV Risk Assessment and Treatment: Debate |
Moderator: Christie Ballantyne, MD Presenters & Discussant: Matthew Budoff, MD Paul Ridker, MD |
| 3:30pm - 4:15pm | Afternoon Break/Exhibit Hall | |
| 4:15pm - 5:15pm | Clinical Controversies in Lipid Management: Case-Based Presentations & Discussion |
Moderator: Christie Ballantyne, MD Presenters: Harold Bays, MD Robert Eckel, MD JoAnne Foody, MD |
| 5:15pm | Closing Remarks | Christie Ballantyne, MD |
| 5:30pm - 6:30pm | Welcome Reception | |
| 7:00pm - 9:00pm | Dinner Symposium A The Next-Generation of Weight-Loss Medications: Expert Recommendations for Managing Obesity, Diabetes & Cardiometabolic Risk Supported by an educational grant from VIVUS, Inc. |
Robert Eckel, MD W. Timothy Garvey, MD Samuel Klein, MD Robert Kushner, MD Arya Sharma, MD, PhD |
| 7:00pm - 9:00pm | Dinner Symposium B Personalized T2DM Management: The Role of Incretin Therapies Along the Continuum of Care This activity is supported by an independent medical education grant from Bristol-Myers Squibb and AstraZeneca, LP |
Robert Chilton, DO Richard Pratley, MD Benjamin Scirica, MD Carol Wysham, MD |
Friday, October 4, 2013
| 6:15am - 7:45am | Breakfast Symposium A Next-Generation Vasodilating Beta Blockers Along the HTN Continuum of Care: Expert Recommendations for Targeting Endothelial Dysfunction, BP, and Cardiometabolic Risk Supported by an educational grant from Forest Laboratories, Inc. |
George Bakris, MD Keith C. Ferdinand, MD Thomas Giles, MD Michael Weber, MD |
| 6:15am - 7:45am | Breakfast Symposium B State-of-the-Art Management of Severe and Familial Hypercholesterolemia: Examining the Role of Antisense Therapy in Clinical Practice Supported by an educational grant from Genzyme, A SANOFI COMPANY |
P. Barton Duell, MD Peter Jones, MD Patrick Moriarty, MD Evan Stein, MD, PhD |
| 8:00am - 8:10am | Opening Remarks | Jay Skyler, MD, MACP |
| 8:10am - 8:40am | Personalized Diabetes Management: Selecting the Right Therapy | John Buse, MD, PhD |
| 8:40am - 9:10am | Insulin Therapy: The State-of-the-Science | Irl Hirsch, MD |
| 9:10am - 9:50am | T1DM 2013: Translating the Latest Advances into Clinical Practice | Robert Eckel, MD Jay Skyler, MD, MACP |
| 9:50am - 10:50am | Morning Break/Exhibit Hall | |
| 10:50am - 11:30am | Pediatric Obesity & T2DM | Moderator: Jay Skyler, MD, MACP Presenters: Sonia Caprio, MD David Ludwig, MD |
| 11:30am - 12:15pm | Diabetes Panel Discussion & Audience Q&A | Moderator: Jay Skyler, MD, MACP Discussants: John Buse, MD Sonia Caprio, MD Robert Eckel, MD Irl Hirsch, MD David Ludwig, MD |
| 12:30pm - 2:00pm | Lunch Symposium A Advances in Basal Insulin Therapy: Expert Analysis of Novel Formulations, Combination Therapies & Delivery Technologies Supported by an educational grant from Novo Nordisk, Inc. |
John Buse, MD, PhD Irl Hirsch, MD Luigi Meneghini, MD Bernard Zinman, MD |
| 12:30pm - 2:00pm | Lunch Symposium B Getting to the Heart of Diabetic Dyslipidemia in High-Risk Patients: Clinical Dilemmas & Novel Approaches to Cardiovascular Risk Reduction Supported by an educational grant from Genentech, A Member of the Roche Group |
Darren McGuire, MD Sunder Mudaliar, MD Jorge Plutzky, MD Jean-Claude Tardif, MD |
| 2:15pm - 2:45pm | Elevated Serum Creatinine: Different Meaning in Different Settings? | George Bakris, MD |
| 2:45pm - 3:15pm | CKD Endpoints in Clinical Trials: Guidance for Clinical Practice | Glenn Chertow, MD |
| 3:15pm - 4:00pm | Afternoon Break/Exhibit Hall | |
| 4:00pm - 4:30pm | Alternative Therapies for HTN: Examining the Evidence |
Robert Brook, MD |
| 4:30pm - 5:30pm | Clinical Controversies in HTN Management: Expert Perspectives & Discussion |
Moderator: George Bakris, MD Case Presenters & Discussants: Rajiv Agarwal, MD Raymond Townsend, MD William White, MD |
| 5:30pm | Closing Remarks | George Bakris, MD |
| 6:30pm - 8:30pm | Dinner Symposium A Obesity Management 2013: Expert Perspectives on the Clinical Impact of Novel & Emerging Therapies Supported by an educational grant from Novo Nordisk, Inc |
Caroline Apovian, MD Robert Eckel, MD Ken Fujioka, MD Robert Kushner, MD |
| 6:30pm - 8:30pm | Dinner Symposium B CV Outcomes for Oral & Incretin-Based Therapies: Examining Cutting-Edge Data & Clinical Implications for Patient Care This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region |
George Bakris, MD William Cushman, MD Vivian Fonseca, MD William White, MD |
Saturday, October 5, 2013
| 6:15am - 7:45am | Breakfast Symposium State-of-the-Art Advances in T2DM Management: Expert Analysis of New & Emerging GLP-1 Receptor Agonists Supported by an educational grant from Lilly USA, LLC |
Thomas Blevins, MD Anne Peters, MD Carol Wysham, MD |
| 8:00am - 8:10am | Opening Remarks | Robert Eckel, MD |
| 8:10am - 9:00am | Keynote Session Brown Fat: Is It Important to Body Weight and Metabolic Risk in Humans? |
C. Ronald Kahn, MD |
| 9:00am - 9:30am | Metabolic Surgery 2013: Patient Selection and Outcomes | Francesco Rubino, MD |
| 9:30am - 10:00am | Look AHEAD: Interpreting the Results for Clinical Practice | David Nathan, MD |
| 10:00am - 10:15am | Morning Break | |
| 10:15am - 11:00am | Diet & Exercise: What's the Optimal Prescription? | Moderator: Robert Eckel, MD Presenters and Discussants: I-Min Lee, MD, ScD Barbara Millen, DPH, RD, RADA |
| 11:00am - 11:30am | Clinical Management of Obesity-Related NAFLD | Samuel Klein, MD |
| 11:30am - 11:50am | Obesity Medicine: Practical Pointers for Your Office or Clinic | Robert Kushner, MD |
| 11:50am - 12:30pm | Clinical Challenges & Practical Strategies for Obesity Management
|
Moderator: Robert Eckel, MD Discussants: C. Ronald Kahn, MD Samuel Klein, MD Robert Kushner, MD I-Min Lee, MD, ScD Barbara Millen, DPH, RD, RADA David Nathan, MD Francesco Rubino, MD |
| 12:30pm | Closing Remarks | Robert Eckel, MD |
A division of Tarsus Medical owned by Tarsus Group
Cardiometabolic Health Congress.
All Rights Reserved.
